RUTI® vaccine
Sponsors
Fundació Institut Germans Trias i Pujol, RUTI Immunotherapeutics S.L., PT. Innovative Pharma Solutions, Archivel Farma S.L.
Conditions
COVID-19Covid-19Sars-CoV2TuberculosisTuberculosis, Pulmonary
Phase 2
Exploratory Study to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers
CompletedNCT04903184
Start: 2021-01-06End: 2021-11-11Updated: 2023-01-26
A Clinical Trial to Evaluate the Efficacy of RUTI® to Reduce the Severity of SARS-CoV-2 Infection (COVID-19)
WithdrawnNCT05115019
Start: 2021-12-31End: 2022-04-30Updated: 2023-02-10
Evaluation of Efficacy and Safety of the Concomitant of RUTI® Immunotherapy With the Standard Treatment in TB Patients
WithdrawnNCT05136833
Start: 2021-12-01End: 2022-12-31Updated: 2022-07-13
Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis
CompletedNCT05455112
Start: 2022-10-29End: 2024-10-30Updated: 2025-12-10